Julia Chen
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Stromal Cell Subsets Modulate T-cell Infiltration in Early Breast Cancer.
Journal: Cancer research communications
Published: November 12, 2025
Cell populations in human breast cancers are molecularly and biologically distinct with age.
Journal: Nature aging
Published: June 13, 2025
Spatial landscapes of cancers: insights and opportunities.
Journal: Nature reviews. Clinical oncology
Published: June 28, 2024
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer.
Journal: Frontiers in oncology
Published: September 17, 2021
The management of HER2-positive early breast cancer: Current and future therapies.
Journal: Asia-Pacific journal of clinical oncology
Published: September 07, 2021
Diagnostic value of 68 Ga-DOTATATE PET-CT imaging for staging of ER+ /PR+ HER2- breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and 18 F-FDG PET-CT in a prospective pilot trial.
Journal: Journal of medical imaging and radiation oncology
Published: December 30, 2020
Window of opportunity treatment in breast cancer.
Journal: ANZ journal of surgery
Published: August 05, 2019
Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report.
Journal: Chinese clinical oncology
Published: October 01, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026